Evofem Biosciences, Inc.
EVFM- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001618835
No open-market purchases or sales by Evofem Biosciences, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Evofem Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Evofem Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Zhang Yan | CFO | 0 | Jan 12, 2024 | 0 |
| Kamdar Kim P. | Director | 0 | Dec 22, 2023 | 0 |
| Pelletier Saundra L | Chief Executive Officer | 186,722 | Apr 26, 2023 | 0 |
| Greer Gillian | Director | – | May 6, 2022 | 0 |
| Rutherford Colin | Director | – | May 6, 2022 | 0 |
| O'Brien Anthony Stephen | Director | – | May 6, 2022 | 0 |
| Rarick Lisa Dale | Director | – | May 6, 2022 | 0 |
| Fitzpatrick Alexander A | General Counsel and Secretary | 516,422 | Feb 23, 2022 | 0 |
| File Justin J. | Chief Financial Officer | 810,982 | Feb 23, 2022 | 0 |
| Barrans Russell | Chief Commercial Officer | 448,554 | Jul 9, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 (view filing)5:13 PM ET | Jan 12 | Same day | Zhang YanCFO | SSale | −104 | $0.0385 | −$4 | −100.0%0 after | |
| Dec 22, 2023 (view filing) | Dec 21 | 1 day | Kamdar Kim P.Director | SSale | −10 | $0.62 | −$6.2 | −100.0%0 after | |
| May 31, 2022 (view filing)8:55 AM ET | May 27 | 4 days | Pelletier Saundra LChief Executive Officer | PPurchase | +141.0K | $0.3525 | +$49.7K | +147.3%236.7K after | |
| Dec 20, 2021 (view filing)4:20 PM ET | Dec 20 | Same day | Fitzpatrick Alexander AGeneral Counsel and Secretary | PPurchase | +25.0K | $0.389 | +$9.72K | +8.0%336.4K after | |
| Dec 20, 2021 (view filing)4:20 PM ET | Dec 20 | Same day | File Justin J.Chief Financial Officer | PPurchase | +40.6K | $0.37 | +$15.0K | +9.2%481.0K after | |
| Dec 20, 2021 (view filing)4:19 PM ET | Dec 20 | Same day | Pelletier Saundra LChief Executive Officer | PPurchase | +135.0K | $0.375 | +$50.6K | +15.9%985.8K after |